New Drug Tracking and Monitoring
|
Traditional drug information sources focus on substances
that have been widely used for decades. But, the natural
outcome of prohibition is an unending progression of novel,
more potent, and less tested drugs. Vendors of these
compounds may mislabel or sell them via "stealth packaging".
In order to reduce the harms associated with the use of new drugs, we monitor the situation through volunteers, forums, and medical professionals; analyze chemicals through EcstasyData; coordinate between interested parties; and publish both online and in print. Documenting emerging drugs poses challenges as we balance the needs of those with access to drugs against the possibility of generating interest in those who have not been exposed to them.
In order to reduce the harms associated with the use of new drugs, we monitor the situation through volunteers, forums, and medical professionals; analyze chemicals through EcstasyData; coordinate between interested parties; and publish both online and in print. Documenting emerging drugs poses challenges as we balance the needs of those with access to drugs against the possibility of generating interest in those who have not been exposed to them.
About the New Drug Tracking Project
More than a century after "temperance" movements
initiated what became the War on Drugs, the
world is facing an unprecedented explosion of
novel unapproved psychoactive chemicals and
plants. The European Monitoring Centre for Drugs
and Drug Addiction reported learning of 73 new
psychoactive drugs in 2012 and 40 in the first half
of 2013.
|
Related Documents #